Neuropathic Pain Database
NCT00669006 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 789
Last updated 2021-10-19
Summary
To establish the infrastructure for a national neuropathic pain database.
To determine the longterm outcome of the management of chronic neuropathic pain including pain relief, disability, and quality of life.
Conditions
- Neuropathic Pain
Sponsors & Collaborators
-
Canada Foundation for Innovation
collaborator OTHER - collaborator INDUSTRY
-
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
lead OTHER
Principal Investigators
-
Dwight Moulin, MD · London Health Sciences Centre- St. Joseph's Health Care
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-04-30
- Primary Completion
- 2012-02-29
- Completion
- 2020-02-24
Countries
- Canada
Study Locations
More Related Trials
-
Vitaccess Real CIDP Registry
NCT07006597 ·Status: NOT_YET_RECRUITING
-
Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Diabetic Peripheral Neuropathic Pain
NCT05177094 ·Status: COMPLETED ·Phase: PHASE2
-
BlueWind Medical Reprieve System for the Treatment of PNP
NCT02062398 ·Status: COMPLETED ·Phase: NA
-
Study in Neuropathic Pain Patients With Peripheral Nerve Injury
NCT00969059 ·Status: COMPLETED ·Phase: PHASE2
-
Understanding Risk Factors and Determinants for Neuropathic Pain
NCT02402361 ·Status: COMPLETED
-
P38 Mitogen-activated Protein (Map) Kinase Inhibitor (SB-681323)Study In Patients With Neuropathic Pain
NCT00390845 ·Status: COMPLETED ·Phase: PHASE2
-
Lidocaine 5% Medicated Plaster in Chronic Neuropathic Postoperative Pain
NCT01155986 ·Status: TERMINATED ·Phase: PHASE2
-
Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)
NCT06968975 ·Status: RECRUITING
-
Flecainide in Treating Patients With Chronic Neuropathic Pain
NCT00002996 ·Status: COMPLETED ·Phase: PHASE2
-
Methadone in Neuropathic Pain
NCT01205516 ·Status: TERMINATED ·Phase: PHASE4
-
In Vitro Studies on Pharmacological Regulation and Genetic Risk Factors of Peripheral Human Nociceptors
NCT00223366 ·Status: COMPLETED
-
Effect of Minocycline on Pain Caused by Nerve Damage
NCT01869907 ·Status: COMPLETED ·Phase: PHASE4
-
Simultaneous Engagement of Networks for Alleviating Pain (SENAP)
NCT07057206 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Effect of Milnacipran in Chronic Neuropathic Low Back Pain
NCT01225068 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Integrity of Down Inhibitor Bundle at Patients Suffering of Neuropathic Pain
NCT01053845 ·Status: COMPLETED ·Phase: PHASE1
-
Home-based EEG Neurofeedback for Chronic Neuropathic Pain
NCT05464199 ·Status: COMPLETED ·Phase: PHASE1
-
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
NCT07285018 ·Status: RECRUITING ·Phase: PHASE2
-
Probing the Role of Sodium Channels in Painful Neuropathies
NCT02243475 ·Status: UNKNOWN
-
Safety and Efficacy of AGN201781 in Neuropathic Pain
NCT00533351 ·Status: TERMINATED ·Phase: PHASE2
-
Chronic Pain, Opioid Use, and Epidermal Nerve Fiber Density
NCT04801498 ·Status: COMPLETED
-
Efficacy and Safety Study of Celecoxib and Pregabalin Compared With Celecoxib Monotherapy, in Patients With Chronic Low Back Pain Having a Neuropathic Component
NCT01838044 ·Status: TERMINATED ·Phase: PHASE4
-
Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Diabetic Peripheral Neuropathic Pain
NCT04476108 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Management of Neuropathic Pain With Ramelteon
NCT00753623 ·Status: TERMINATED ·Phase: NA
-
Efficacy Study of Botox to Treat Neuropathic Pain
NCT00527202 ·Status: COMPLETED ·Phase: PHASE4
-
Long Term Outcome After Serial Lidocaine Infusion in Peripheral Neuropathic Pain
NCT02217267 ·Status: COMPLETED ·Phase: PHASE3